邦
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chhattisgarh
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu and Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- New Delhi
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttarakhand
- West Bengal
EB
IN
ENZENE BIOSCIENCES
Enzene is an end-to-end CDMO with services spanning discovery, development, and commercial supply, operating integrated ...
实验室 Laboratory
- 联系人: -
- 联系电话: -
- 电子邮箱: -
- 企业地址: No. 473 D2, 13th Cross IV Phase, Peenya Industrial Area, Bangalore - 560058
- 所在州省: Karnataka
- 企业官网: -
- 企业类型: -
- 员工人数: -
- 企业税号: -
- 年营业额: -
- 最后更新: 2026-03-23
-
企业简介:
Enzene is an end-to-end CDMO with services spanning discovery, development, and commercial supply, operating integrated sites in Pune (India) and New Jersey (USA). As a pioneer in next-generation biologics technologies, Enzene is disrupting the existing biologics manufacturing paradigm with its patented EnzeneX™ technology—the first fully-connected continuous manufacturing™ (FCCM™) platform validated for commercial biologics supply. We partner with innovators and biosimilar developers to deliver accelerated time-to-market, increased production yields, and cost reductions across a broad range of biologic modalities. Committed to pushing the boundaries of biologics manufacturing innovation, Enzene is striving to reduce monoclonal antibody production costs to below $40 per gram by 2025. For more information on Enzene Biosciences Ltd., a subsidiary of Alkem Laboratories Ltd, please visit www.enzene.com
-
主营产品: